Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy

Interleukin-33 (IL-33) and its “decoy” receptor soluble ST2 (sST2) are involved in the development of chronic inflammation and cancer. We explored IL-33 and sST2 as a potential prognostic marker in patients with metastatic and locally advanced pancreatic ductal adenocarcinoma (PDAC). IL-33 and sST2...

Descripción completa

Detalles Bibliográficos
Autores principales: Kieler, Markus, Unseld, Matthias, Wojta, Johann, Kaider, Alexandra, Bianconi, Daniela, Demyanets, Svitlana, Prager, Gerald W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244890/
https://www.ncbi.nlm.nih.gov/pubmed/30426271
http://dx.doi.org/10.1007/s12032-018-1223-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244890/
https://www.ncbi.nlm.nih.gov/pubmed/30426271
http://dx.doi.org/10.1007/s12032-018-1223-3

Ejemplares similares